<code id='BB211194AE'></code><style id='BB211194AE'></style>
    • <acronym id='BB211194AE'></acronym>
      <center id='BB211194AE'><center id='BB211194AE'><tfoot id='BB211194AE'></tfoot></center><abbr id='BB211194AE'><dir id='BB211194AE'><tfoot id='BB211194AE'></tfoot><noframes id='BB211194AE'>

    • <optgroup id='BB211194AE'><strike id='BB211194AE'><sup id='BB211194AE'></sup></strike><code id='BB211194AE'></code></optgroup>
        1. <b id='BB211194AE'><label id='BB211194AE'><select id='BB211194AE'><dt id='BB211194AE'><span id='BB211194AE'></span></dt></select></label></b><u id='BB211194AE'></u>
          <i id='BB211194AE'><strike id='BB211194AE'><tt id='BB211194AE'><pre id='BB211194AE'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          Wikipedia

          author:focus    - browse:98
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          entertainment